Rankings
▼
Calendar
ARVN FY 2024 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$907M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$263M
+235.5% YoY
Gross Profit
$263M
100.0% margin
Operating Income
-$250M
-95.0% margin
Net Income
-$199M
-75.5% margin
EPS (Diluted)
$-2.77
Cash Flow
Operating Cash Flow
-$259M
Free Cash Flow
-$261M
Stock-Based Comp.
$88M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$530M
Stockholders' Equity
$562M
Cash & Equivalents
$101M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$263M
$79M
+235.5%
Gross Profit
$263M
$79M
+235.5%
Operating Income
-$250M
-$402M
+37.7%
Net Income
-$199M
-$367M
+45.8%
← Q4 2023
All Quarters
Q1 2024 →